Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

NCT04849000 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

709

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia
Mixed Hyperlipemia

Interventions

DRUG: SHR-1209
DRUG: SHR-1209 Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.